ArisInfra Solutions Ltd, supported by PharmEasy CEO Siddharth Shah, has submitted initial documents to the capital markets regulator Sebi to raise Rs 600 crore through an initial public offering (IPO). According to the draft red herring prospectus (DRHP), the IPO will be a fresh issue of equity shares without any offer for sale (OFS) component.
Comments
Post a Comment